A new way to run clinical research in sleep medicine: why does it matter?

Understand more about new methods of clinical research in sleep medicine, including how large data sets are being utilised and the benefits and challenges of Real-World Evidence.

This is a secured video. To access it for the first time you must fill-in your email address above.

Key facts

World Sleep Congress 2022
With Kimberley Sterling, Christoph Schöbel, Jean-Louis Pépin, Anita Simonds
New ways to run clinical research in sleep medicine

Content

In this webinar, Kimberly Sterling will explain how a more holistic view of patients based on Real-World Evidence (RWE) can benefit sleep apnoea therapy management. She’ll introduce a range of RWE examples collected from PAP patients and explain the benefits and challenges using this kind of data can bring. Jean-Louis Pépin delivers an outline of the results of the ALASKA project, an analysis of a total of 480,000 CPAP users in the French healthcare system. Plus, he explains findings around the effect of telemedicine/telemonitoring on PAP adherence. Anita Simonds walks through the current evolution of OSAHS guidelines and asks: can RWE and virtual pathways influence policy in the future?

The participants were provided with a nominal financial incentive for providing the following testimonial.

Speakers

Christoph Schöbel

Professor of Sleep Medicine and Telemedicine
Head of the Centre for Sleep Medicine, University Hospital of Essen, Germany

Kimberley Sterling

Vice President, Health Economics and Outcomes Research, ResMed, USA

Jean-Louis Pépin

Professor of Clinical Physiology, Grenoble Alpes University, France

Anita Simonds

Consultant in Respiratory and Sleep Medicine, Royal Brompton Hospital, London
Professor Emeritus of Respiratory and Sleep Medicine, National Heart and Lung Institute, Imperial College London
Former Vice President and President Elect of the European Respiratory Society (ERS)